Merck
MRK
#44
Rank
โ‚ฌ255.22 B
Marketcap
103,23ย โ‚ฌ
Share price
2.58%
Change (1 day)
28.00%
Change (1 year)

Revenue for Merck (MRK)

Revenue in 2025 (TTM): โ‚ฌ56.44 Billion

According to Merck's latest financial reports the company's current revenue (TTM ) is โ‚ฌ56.22 Billion. a decrease over the revenue in the year 2024 that were of โ‚ฌ61.66 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Merck from 1996 to 2025

Annual revenue

Year Revenue Change
2025 โ‚ฌ55.34 B-10.25%
2024 โ‚ฌ61.66 B13.4%
2023 โ‚ฌ54.37 B-1.61%
2022 โ‚ฌ55.26 B28.51%
2021 โ‚ฌ43.00 B17.93%
2020 โ‚ฌ36.46 B-12.79%
2019 โ‚ฌ41.81 B13.1%
2018 โ‚ฌ36.97 B10.56%
2017 โ‚ฌ33.43 B-11.64%
2016 โ‚ฌ37.84 B4.76%
2015 โ‚ฌ36.12 B4.02%
2014 โ‚ฌ34.72 B8.92%
2013 โ‚ฌ31.88 B-10.77%
2012 โ‚ฌ35.73 B-3.42%
2011 โ‚ฌ36.99 B7.01%
2010 โ‚ฌ34.57 B80.59%
2009 โ‚ฌ19.14 B12.22%
2008 โ‚ฌ17.06 B2.94%
2007 โ‚ฌ16.57 B-3.39%
2006 โ‚ฌ17.15 B-7.68%
2005 โ‚ฌ18.58 B9.89%
2004 โ‚ฌ16.91 B-5.32%
2003 โ‚ฌ17.86 B-57.88%
2002 โ‚ฌ42.40 B-21.52%
2001 โ‚ฌ54.02 B26.1%
2000 โ‚ฌ42.84 B31.79%
1999 โ‚ฌ32.51 B43.43%
1998 โ‚ฌ22.66 B13.8%
1997 โ‚ฌ19.91 B19.21%
1996 โ‚ฌ16.70 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ81.45 B 44.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ49.01 B-12.82%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ54.11 B-3.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ38.33 B-31.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ56.36 B 0.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ31.78 B-43.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ46.63 B-17.06%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚ฌ41.67 B-25.87%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ37.85 B-32.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚ฌ14.92 B-73.45%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel